SEGLUROMET 2.5 mg/1

Segluromet 2.5 mg/1 combines ertugliflozin and metformin hydrochloride for oral use. This medication supports glucose management in adults with type 2 diabetes. Learn about its uses, effects, and precautions.

Segluromet 2.5 mg/1 is a combination medication used to help manage blood sugar levels in adults with type 2 diabetes. It contains two active ingredients: ertugliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, and metformin hydrochloride, a biguanide. Together, they work to lower blood glucose levels. This medication is often prescribed as part of a broader treatment plan that includes diet and exercise.

Common effects of Segluromet 2.5 mg/1 may include symptoms such as nausea, diarrhea, and headache. Some individuals may experience urinary tract infections or genital mycotic infections. It's important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Segluromet 2.5 mg/1 should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may not be suitable for everyone, especially those with certain medical conditions like kidney problems or a history of lactic acidosis. Always inform your healthcare provider about any other medications you are taking.

Segluromet 2.5 mg/1 may interact with certain medications, including those that affect kidney function or blood sugar levels. Alcohol consumption should be avoided as it can increase the risk of lactic acidosis. It is also important to be cautious with medications that may cause dehydration or affect electrolyte balance.